Cloning and characterization of the 5′ flanking region of the HGFIN gene indicate a cooperative role among p53 and cytokine-mediated transcription factors: Relevance to cell cycle regulation

Cell Cycle

Volumn 4, Issue 2, 2005, Pages 314-321

  Metz, Rebecca L ^a,b   Yehia, Ghassan ^a   Fernandes, Helen ^a   Donnelly, Robert J ^a   Rameshwar, Pranela ^a,b  

^a UMDNJ NJMS   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cell cycle; Cytokines; HGFIN; Neurokinin receptors; nmb; Osteoactivin; p53; Tachykinins

Indexed keywords

MEMBRANE PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE; COMPUTER ANALYSIS; CONSENSUS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA FLANKING REGION; DOWN REGULATION; EXON; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; TUMOR GROWTH;

EID: 25444516753     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.2.1468     Document Type: Article

References (25)

1. Alenzi FQ. Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci 2004; 61:99-102.
2. Bandari PS, Qian J, Yehia G, Joshi DD, Maloof PB, Potian J, Oh HS, Gascon P, Harrison JS, Rameshwar P. Hematopoietic Growth Factor Inducible Neurokinin-1 type (HGFIN) gene: A transmembrane protein that is similar to neurokinin-1 interacts with substance P. Regul Pept 2003; 111:169-78.
3. Cui YF, Lord BI, Woolford LB, Testa NG. The relative spatial distribution of in vitro-CFCs in the bone marrow, responding to specific growth factors. Cell Prolif 1996; 29:243-57.
4. Ding HF, Fisher DE. Induction of apoptosis in cancer: New therapeutic opportunities. Ann Med 2002; 34:451-69.
5. Harmar AJ, Amstron A, Pascall JC, Chapman K, Rosie R, Curtis A. cDNA sequence of human beta-preprotachykinin, the common precursor to substance P and neurokinin A. FEBS Lett 1986; 208:67-72.
6. Hoh JSJ, Parrado T, Edington J, Levine AJ, Ott J. The p53MH algorithm and its applsication in detecting p53-responsive genes. Proc Natl Acad Sci USA 2002; 99:8467-72.
7. Kuckelkorn U, Ferreira EA, Drung I, Liewer U, Kloetzel PM, Theobald M. The effect of the interferon-gamma-inducible processing machinery on the generation of a naturally tumor-associated human cytotoxic T lymphocyte epitope within a wild-type and mutant p53 sequence context. Eur J Immunol 2002; 32:1368-75.
8. McIvor Z, Sibyll H, Fiegler H, Schroeder T, Stocking C, Just U, Cross M. Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation. Exp Hematol 2003; 31:39-47.
9. Muller-Sieburg CE, Deryugina E. The stromal cells' guide to the stem cell universe. Stem Cells 1995; 13:477-86.
10. Owen TA, Smock SL, Prakash S, Pinder L, Brees D, Krull D, Castleberry TA, Clancy YC, Marks SC, Safadi FF, Popoff SN. Identification and characterization of the genes encoding human and mouse osteoactivin. Crit Rev Eukaryot Gene Expr 2003; 13:205-20.
11. Oh HS, Moharita A, Potian JG, Whitehead IP, Livingston JC, Castro TA, Patel PS, Rameshwar P. Bone marrow stroma influences TGF-β production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells. Cancer Res 2004; 64:6327-36.
12. Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P. Veto-like activity of mesenchymal stem cells (MSC): Functional discrimination between cellular responses to alloantigen and recall antigens. J Immunol 2003; 171:3426-34.
13. Qian J, Yehia G, Molina C, Fernandes A, Donnelly RJ, Anjaria DJ, Gascón P, Rameshwar P. Cloning of human preprotachykinin-I promoter and the role of cAMP response elements in its expression by IL-1 and stem cell factor. J Immunol 2001; 166:2553-61.
14. Rameshwar P, Narayanan R, Qian J, Denny TN, Colon C, Gascón P. NF-κB as a central mediator in the induction of TGF-β in monocytes from patients with idiopathic myelofibrosis: An inflammatory response beyond the realm of homeostasis. J Immunol 2000; 165:2271-77.
15. Rao G, Patel PS, Idler SP, Maloof P, Potian JA, Gascon P, Rameshwar P. Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: A model of early cancer progression. Cancer Res 2004; 64:2874-81.
16. Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan CT, Bigner DD, Counter CM, Wang XF. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 2003; 278:15951-57.
17. Rocha S, Campbell KJ, Roche KC, Perkins ND. The p53-inhibitor pfifithrin-α inhibits firefly luciferase activity in vivo and in vitro. BMC Mol Biol 2003; 4:9.
18. Safadi FF, Smock SL, Rico MC, Owen TA, Popoff SN. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem 2002; 84:12-26.
19. Selim AAS, Abdelmagid M, Kanaan RA, Smock SL, Owen TA, Popoff SN, Safadi FF. Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro. Crit Rev Eukaryot Gene Expr 2003; 13:265-75.
20. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1:233-40.
21. Thomas RS, Tymms MJ, McKinlay LH, Shannon MF, Seth A, Kola I. ETS1, NF kappa B and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene 1997; 14:2845-55.
22. Vadlamudi RK, Kumar R. p21-activated kinase 1: An emerging therapeutic target. Cancer Treat Res 2004; 119:77-88.
23. Wang S, El-Deiry WS. The p53 pathway: Targets for the development of novel cancer therapeutics. Cancer Treat Res 2004; 119:175-87.
24. Weterman MA, Ajubi N, van Dinter I, Degen W, van Muijen G, Ruiter D, Bloemers H. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 1995; 60:73-81.
25. Yamada T, Abe M, Higashi T, Yamamoto H, Kihara-Negishi K, Sakurai T, Shirai T, Oikawa T. Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells. Blood 2001; 97:2300-07.